Epstein-Barr virus DNA, intermediate filaments and epithelial membrane antigen in nasopharyngeal carcinoma

被引:0
|
作者
Friedrich, RE
Bartel-Friedrich, S
Lobeck, H
Niedobitek, G
Arps, H
机构
[1] Univ Hamburg, Eppendorf Univ Hosp, Nordwestdeutsch Kieferklin, Klin MKG Chirurg,Dept Oral & Maxillofacial Surg, D-20246 Hamburg, Germany
[2] Univ Halle Wittenberg, Halle, Germany
[3] Free Univ Berlin, Charite, Dept Pathol, D-1000 Berlin, Germany
[4] Free Univ Berlin, Benjamin Franklin Hosp, Dept Pathol, D-1000 Berlin, Germany
[5] Gen Hosp, Dept Pathol, Fulda, Germany
关键词
undifferentiated carcinoma; nasopharyngeal carcinoma; intermediate filaments; Epstein-Barr virus; cytokeratins;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to investigate the expression of intermediate filaments (cytokeratin, vimentin), epithelial membrane antigen (EMA) and the presence of Epstein-Barr virus (EBV) DNA in undifferentiated nasophalyngeal carcinoma (NPC). A high incidence of nuclear signals in NPC was Sound in primaries and regional lymph node metastases (70%), using S-35-labelled probes of EBV plasmids for in-situ hybridization. Keratinizing squamous cell carcinomas were EBV-negative. All carcinomas were immune-reactive for cytokeratin (KL-1). 45% of the carcinomas were positive for vimentin. The expression of epithelial membrane antigen was restricted to epithelial cells and reduced in NPC as compared to the distribution pattern of cytokeratin. Both EBV DNA and vimentin in NPC were present in 9 cases. However, in 5 cases NPG were harboring EBV but were not immunoreactive for anti-vimentin antibodies. In no case was a vimentin-positive NPC also EBV-negative. The identification of cytokeratin subtypes revealed no specific cytokeratin pattern in NPC. The expression of vimentin in NPC is not specific for EBV, but seems to reflect the loss of intel-epithelial contact in anaplastic carcinomas.
引用
收藏
页码:4909 / 4916
页数:8
相关论文
共 50 条
  • [31] Nasopharyngeal Carcinoma and Its Association with Epstein-Barr Virus
    Vasudevan, Harish N.
    Yom, Sue S.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (05) : 963 - 971
  • [32] EPSTEIN-BARR VIRUS IN BURKITTS LYMPHOMA AND NASOPHARYNGEAL CARCINOMA
    GUNVEN, P
    KLEIN, G
    HENLE, G
    HENLE, W
    CLIFFORD, P
    NATURE, 1970, 228 (5276) : 1053 - &
  • [33] The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
    Li, You Quan
    Khin, Ni Sann
    Chua, Melvin L. K.
    CANCER BIOLOGY & MEDICINE, 2018, 15 (01) : 1 - 5
  • [34] Role of Epstein-Barr virus in the development of nasopharyngeal carcinoma
    Zhang, Hui
    Wang, Jing
    Yu, Dan
    Liu, Yan
    KaiXue
    Zhao, Xue
    OPEN MEDICINE, 2017, 12 (01): : 171 - 176
  • [35] Nasopharyngeal Carcinoma: An Evolving Role for the Epstein-Barr Virus
    Raab-Traub, Nancy
    EPSTEIN BARR VIRUS, VOL 1: ONE HERPES VIRUS: MANY DISEASES, 2015, 390 : 339 - 363
  • [36] Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis
    Burgos, JS
    MEDICAL ONCOLOGY, 2005, 22 (02) : 113 - 121
  • [37] STUDIES ON THE ASSOCIATION OF THE EPSTEIN-BARR VIRUS WITH NASOPHARYNGEAL CARCINOMA
    GLASER, R
    CHENG, YC
    LANG, CM
    HEAD & NECK SURGERY, 1981, 3 (03): : 259 - 259
  • [38] EPSTEIN-BARR VIRUS AND NASOPHARYNGEAL CARCINOMA - IS THERE AN ETIOLOGIC RELATIONSHIP
    HENDERSON, BE
    LOUIE, EW
    JING, JS
    ALENA, B
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1977, 59 (05) : 1393 - 1395
  • [39] Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma
    Niedobitek, G
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2000, 53 (05): : 248 - 254
  • [40] The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
    You Quan Li
    Ni Sann Khin
    Melvin L.K.Chua
    Cancer Biology & Medicine, 2018, (01) : 1 - 5